Edwards Lifesciences Corp (EW) recently saw its stock price decline by 3.5%, prompting a re-evaluation of its market position. GuruFocus's GF Value analysis suggests the medical technology company is currently undervalued by 16.3%, potentially presenting a buying opportunity.
Edwards Lifesciences Stock Undervalued After 3.5% Drop, GuruFocus Says
Edwards Lifesciencesmedical-techstock-analysisvaluationundervalued

